Mixer or shaker accessories or attachments

KRN5, a derivative of KRN2, is an oral active Nuclear factor of activated T cells 5 (NFAT5) suppressor, with an IC 50 of 750 nM. KRN5 has potential to treat NFAT5-mediated Chronic ArthritisIn VitroKRN5 is less toxic than BBR as determined by a

KH-CB20, an E/Z mixture, is a potent and selective inhibitor of CLK1 and the closely related isoform CLK4 , with an IC 50 of 16.5 nM for CLK1 . KH-CB20 can also inhibit DYRK1A ( IC 50 =57.8 nM) and CLK3 ( IC 50 =488 nM)In VitroKH-CB20 shows

KRN5, a derivative of KRN2, is an oral active Nuclear factor of activated T cells 5 (NFAT5) suppressor, with an IC 50 of 750 nM. KRN5 has potential to treat NFAT5-mediated Chronic ArthritisIn VitroKRN5 is less toxic than BBR as determined by a

KRN5, a derivative of KRN2, is an oral active Nuclear factor of activated T cells 5 (NFAT5) suppressor, with an IC 50 of 750 nM. KRN5 has potential to treat NFAT5-mediated Chronic ArthritisIn VitroKRN5 is less toxic than BBR as determined by a

KRN5, a derivative of KRN2, is an oral active Nuclear factor of activated T cells 5 (NFAT5) suppressor, with an IC 50 of 750 nM. KRN5 has potential to treat NFAT5-mediated Chronic ArthritisIn VitroKRN5 is less toxic than BBR as determined by a

KRN5, a derivative of KRN2, is an oral active Nuclear factor of activated T cells 5 (NFAT5) suppressor, with an IC 50 of 750 nM. KRN5 has potential to treat NFAT5-mediated Chronic ArthritisIn VitroKRN5 is less toxic than BBR as determined by a

KRN5, a derivative of KRN2, is an oral active Nuclear factor of activated T cells 5 (NFAT5) suppressor, with an IC 50 of 750 nM. KRN5 has potential to treat NFAT5-mediated Chronic ArthritisIn VitroKRN5 is less toxic than BBR as determined by a

KH-CB20, an E/Z mixture, is a potent and selective inhibitor of CLK1 and the closely related isoform CLK4 , with an IC 50 of 16.5 nM for CLK1 . KH-CB20 can also inhibit DYRK1A ( IC 50 =57.8 nM) and CLK3 ( IC 50 =488 nM)In VitroKH-CB20 shows

KH-CB20, an E/Z mixture, is a potent and selective inhibitor of CLK1 and the closely related isoform CLK4 , with an IC 50 of 16.5 nM for CLK1 . KH-CB20 can also inhibit DYRK1A ( IC 50 =57.8 nM) and CLK3 ( IC 50 =488 nM)In VitroKH-CB20 shows

KH-CB20, an E/Z mixture, is a potent and selective inhibitor of CLK1 and the closely related isoform CLK4 , with an IC 50 of 16.5 nM for CLK1 . KH-CB20 can also inhibit DYRK1A ( IC 50 =57.8 nM) and CLK3 ( IC 50 =488 nM)In VitroKH-CB20 shows

KML110.

KML110.